These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 12622915

  • 1. [Changes of plasma serotonin precursor metabolite concentrations in postmenopausal women with hot flushes].
    Chen Y, Lü X, Huang Y, Xin X, Ye X.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):726-8. PubMed ID: 12622915
    [Abstract] [Full Text] [Related]

  • 2. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women.
    Słopień R, Meczekalski B, Warenik-Szymankiewicz A.
    Climacteric; 2003 Mar; 6(1):53-7. PubMed ID: 12725665
    [Abstract] [Full Text] [Related]

  • 3. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 4. Hot flushes during the menopause transition: a longitudinal study in Australian-born women.
    Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG.
    Menopause; 2005 Dec; 12(4):460-7. PubMed ID: 16037762
    [Abstract] [Full Text] [Related]

  • 5. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
    Guthrie JR, Dennerstein L, Hopper JL, Burger HG.
    Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
    [Abstract] [Full Text] [Related]

  • 6. Persistent hot flushes in older postmenopausal women.
    Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF.
    Arch Intern Med; 2008 Apr 28; 168(8):840-6. PubMed ID: 18443259
    [Abstract] [Full Text] [Related]

  • 7. Hot flushes, bone mineral density, and fractures in older postmenopausal women.
    Huang A, Grady D, Blackwell T, Bauer D.
    Obstet Gynecol; 2007 Apr 28; 109(4):841-7. PubMed ID: 17400844
    [Abstract] [Full Text] [Related]

  • 8. Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.
    Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T.
    Am J Obstet Gynecol; 2004 Jul 28; 191(1):121-31. PubMed ID: 15295352
    [Abstract] [Full Text] [Related]

  • 9. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
    Im JA, Lee JW, Lee HR, Lee DC.
    Maturitas; 2006 Apr 20; 54(1):65-71. PubMed ID: 16198517
    [Abstract] [Full Text] [Related]

  • 10. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes.
    Tuomikoski P, Mikkola TS, Hämäläinen E, Tikkanen MJ, Turpeinen U, Ylikorkala O.
    Menopause; 2010 Apr 20; 17(1):145-51. PubMed ID: 19602991
    [Abstract] [Full Text] [Related]

  • 11. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW, Chen WL, Yu Q, Song YH, Zhou J, Zhang DY.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 20; 38(2):98-101. PubMed ID: 12783698
    [Abstract] [Full Text] [Related]

  • 12. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct 20; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 13. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan 20; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 15. Plasma nitrite/nitrate levels in women with postmenopausal hot flushes.
    Tuomikoski P, Ylikorkala O, Mikkola TS.
    Climacteric; 2012 Apr 20; 15(2):153-6. PubMed ID: 22017369
    [Abstract] [Full Text] [Related]

  • 16. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol.
    Carretti N, Florio P, Reis FM, Comai S, Petraglia F, Costa CV.
    Climacteric; 2007 Oct 20; 10(5):393-9. PubMed ID: 17852142
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
    Nahas EA, Nahas-Neto J, Orsatti FL, Carvalho EP, Oliveira ML, Dias R.
    Maturitas; 2007 Nov 20; 58(3):249-58. PubMed ID: 17913408
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L, Gass M, Constantine G, Olivier S, Study 315 Investigators.
    Obstet Gynecol; 2008 Jan 20; 111(1):77-87. PubMed ID: 18165395
    [Abstract] [Full Text] [Related]

  • 19. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S, Walsh BW, Ciaccia AV, Siddhanti S, Rosen AS, Plouffe L.
    Obstet Gynecol; 2004 Feb 20; 103(2):267-73. PubMed ID: 14754694
    [Abstract] [Full Text] [Related]

  • 20. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H, Al-Azzawi F, UK VR Multicentre Trial Group.
    BJOG; 2003 Aug 20; 110(8):753-9. PubMed ID: 12892687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.